Showing results (491-500 of 617) with videos related to

Sort By:
Pageof 62
The American Journal of Pathology|October 7, 2004
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasionAnil K Sood, Jeremy E Coffin, Galen B Schneider, et al.
Gynecologic Oncology|June 30, 2007
STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot studyMichael R Milam, Jian Gu, Hushan Yang, et al.
Gynecologic Oncology|May 23, 2022
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomesDavid M Gershenson, Charlotte C Sun, Shannon N Westin, et al.
Gynecologic Oncology|May 7, 2008
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneumPedro T Ramirez, Kathleen M Schmeler, Michael R Milam, et al.
Gynecologic Oncology|June 25, 2003
Overexpression of kallikrein 10 in epithelial ovarian carcinomasHyun S Shvartsman, Karen H Lu, John Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complexAgapito Castilleja, Darrick Carter, Clay L Efferson, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2007
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysisKwong-Kwok Wong, Karen H Lu, Anais Malpica, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
Pageof 62